Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.
Illumina is a biotechnology company founded in 1998 located in San Diego, California, developing and selling instruments, reagents, and services for DNA sequencing applications.
A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases
A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
A company developing small molecule therapies to treat cancer
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
A company that develops and commercializes products for the treatment of dermatological diseases
A biotechnology company researching and developing therapies to increase human lifespan.
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
A biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated biological changes.
A company developing treatments for dermatology and immunology.
A biotechnology company developing therapies to cure rare diseases
A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.
A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases
A biopharmaceutical company focused on the research and development of antibiotics to treat serious infections
A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions
A pharmaceutical company that develops drugs to treat cancer and other major disease
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
An immunotherapy company developing therapies to cancer
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
A company that deveops therapeutics for depression, CNS and ophthalmological disorders